Otsuka : Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
April 28, 2022 at 12:55 pm IST
Share
April 28, 2022
Company Name
Otsuka Holdings Co., Ltd.
Name of Representative
Tatsuo Higuchi
President and Representative Director, CEO
Code Number
4578, Prime Market of Tokyo Stock Exchange
Contact
Yuji Kogure
Director, Investor Relations Department
(Phone: +81-3-6361-7411）
Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
Otsuka Holdings Co., Ltd. (the "Company") announces that payment of disposal of treasury shares has been made as shown in the following table. For further information, please refer to "Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation" which was issued on March 30, 2022.
Overview of the Disposal of Treasury Shares
(1)Disposal date
April 28, 2022
(2)Class and number of shares to be disposed
241,920 shares of common shares of the Company;
(3)Disposal value
¥4,271 per share
(4)Total disposal value
¥1,033,240,320
(5)Recipients of allocation and the number thereof; number of shares to be disposed
Directors of the Company (excluding outside directors): 8; 102,400 shares Directors of the Company's subsidiary: 39; 139,520 shares
Attachments
Original Link
Original Document
Permalink
Disclaimer
Otsuka Holdings Co. Ltd. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 07:24:06 UTC.
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),
OTSUKA HOLDINGS CO., LTD. 
